Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More

Trevena

Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments

CHESTERBROOK, PA — Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company, spotlighted its first-quarter achievements and financial standing, underscoring advancements in its novel treatment for chronic pain and epilepsy and strategic …

Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments Read More